Associate Professor, Medicine, University of Illinois College of Medicine
Pulmonology
Dr. Roberto F. Machado, MD
|
|
Give Review
Doctor Roberto F. Machado, MD is an expert in the field of Pulmonology. He researched medicine at Federal University of Rio Grande do Sul School of Medicine. Roberto Machado is also a published doctor. He has 75 publication published. The most recent publication is: Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Roberto Machado accepts all Medicare patients.
Publications
- Increased consumption and vasodilatory effect of nitrite during exercise.
- Pathophysiology and treatment of Pulmonary hypertension in sickle cell disease.
- Software-Based Hybrid Perfusion SPECT/CT Provides Diagnostic Accuracy When Other Pulmonary Embolism Imaging Is Indeterminate.
- Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and CNS Homeostasis.
- The imitation game in Pulmonary arterial hypertension. Sex, bone morphogenetic protein receptor, and the estrogen paradox.
- High sodium causes Hypertension: evidence from clinical trials and animal experiments.
- Deficiency of Akt1, but not Akt2, Attenuates the Development of Pulmonary Hypertension.
- Pulmonary hypertension in sickle cell disease.
- The Sphingosine Kinase 1 / Sphingosine-1-Phosphate Pathway in Pulmonary Arterial Hypertension.
- Reply: Practice Guideline for Pulmonary Hypertension in Sickle Cell: Direct Evidence Needed before Universal Adoption.
- Computed tomography correlates with cardioPulmonary hemodynamics in Pulmonary hypertension in adults with sickle cell disease.
- Mechanistic Insights and Characterization of Sickle Cell Disease Associated Cardiomyopathy.
- Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory Lung injury.
- ARTS: automated randomization of multiple traits for study design.
- The Hypoxic Response Contributes to Altered Gene Expression and Pre-Capillary Pulmonary Hypertension in Patients with Sickle Cell Disease.
- Haemoglobinuria is associated with Chronic kidney disease and its progression in patients with sickle cell anaemia.
- Pulmonary hypertension associated with Chronic hemolytic anemia and other blood disorders.
- Differences in the clinical and genotypic presentation of sickle cell Disease around the world.
- A Novel p38 Mitogen-activated Protein Kinase/Elk-1 Transcription Factor-dependent Molecular Mechanism Underlying Abnormal Endothelial Cell Proliferation in Plexogenic ...
- Effect of Extended-Release Niacin on Serum Lipids and on Endothelial Function in Adults With Sickle Cell Anemia and Low High-Density Lipoprotein Cholesterol Levels.
- Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing.
- Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute Respiratory distress syndrome.
- Pharmacologic treatments for Pulmonary hypertension: exploring pharmacogenomics.
- Circulating endothelial progenitor cells in adults with sickle cell Disease.
- Optimization of isolated perfused/ventilated mouse lung to study hypoxic Pulmonary vasoconstriction.
- The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
- Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
- Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease.
- Evaluation of a reliable and cost-effective method of DNA isolation for mouse genotyping.
- Peripheral blood gene expression as a novel genomic biomarker in complicated Sarcoidosis.
- Sphingosine-1-Phosphate Receptor 3 is a Novel Biomarker in Acute Lung Injury.
- A Novel Molecular Signature for Elevated Tricuspid Regurgitation Velocity in Sickle Cell Disease.
- Conflicting physiological and genomic cardioPulmonary effects of recruitment maneuvers in murine acute lung injury.
- NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell Disease.
- Hospitalization for pain in patients with sickle cell Disease treated with sildenafil for elevated TRV and low exercise capacity.
- Pulmonary complications of hemoglobinopathies.
- Perivascular T Cell Infiltration Leads to Sustained Pulmonary Artery Remodeling After Endothelial Cell Damage.
- Pulmonary hypertension in hemolytic disorders: Pulmonary vascular disease: the global perspective.
- Segmentation and quantification of Pulmonary artery for noninvasive CT assessment of sickle cell secondary Pulmonary hypertension.
- Diagnosis and management of Pulmonary hypertension in systemic sclerosis.
- Identifying chronic obstructive pulmonary disease and Asthma by exhaled breath analysis: does the (e)Nose know?
- Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection.
- CT and image processing non-invasive indicators of sickle cell secondary Pulmonary hypertension.
- Platelet activation in patients with sickle disease, hemolysis-associated Pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.
- Hemodynamic and functional assessment of patients with sickle cell disease and Pulmonary hypertension.
- Nitric oxide-based therapies in sickle cell Disease: the evidence continues to mount.
- Diastolic dysfunction is an independent risk factor for death in patients with sickle cell Disease.
- Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, Pulmonary hypertension, and death in patients with sick...
- Erythrocytes are the major intravascular storage sites of nitrite in human blood.
- Detection of Lung cancer by sensor array analyses of exhaled breath.
- Nitric oxide and Pulmonary arterial pressures in Pulmonary hypertension.
- Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective Pulmonary vasodilator.
- Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.
- Risk factors for death in 632 patients with sickle cell Disease in the United States and United kingdom.
- Upregulated copper transporters in hypoxia-induced Pulmonary hypertension.
- Nontuberculous mycobacterial Disease mortality in the United States, 1999-2010: a population-based comparative study.
- Transcriptional Events during the Recovery from MRSA Lung Infection: A Mouse Pneumonia Model.
- Sildenafil therapy in patients with sickle cell disease and Pulmonary hypertension.
- Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
- Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics?
- Severity of Pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.
- Combination erythropoietin-hydroxyurea therapy in sickle cell Disease: experience from the National Institutes of Health and a literature review.
- N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell Disease.
- Sildenafil in the treatment of Pulmonary hypertension.
- Sickle cell anemia-associated Pulmonary arterial hypertension.
- Sodium nitrite promotes regional blood flow in patients with sickle cell Disease: a phase I/II study.
- Pulmonary hypertension in Chronic respiratory disorders: we need to learn more.
- Endothelin receptor antagonists for Pulmonary hypertension in adult patients with sickle cell disease.
- Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with Pulmonary hypertension, desaturation, haemolysis, organ dysfu...
- Categorization and impact of Pulmonary hypertension in patients with advanced COPD.
- Echocardiographic markers of elevated Pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents ...
- Exercise capacity and haemodynamics in patients with sickle cell disease with Pulmonary hypertension treated with bosentan: results of the ASSET studies.
- Survival in Pulmonary arterial hypertension: A brief review of registry data.
- Diagnostic and therapeutic algorithm for Pulmonary arterial hypertension.
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Education
-
Cleveland Clinic Foundation -
Jackson Memorial Hospital - Jackson Health System -
Federal University of Rio Grande do Sul School of Medicine
Hospital
-
Mercy Hospital and Medical Center -
University of Illinois Hospital & Health Sciences System
Drug Facts
| NPI NUMBER | 1942268172 | |
| NPPES Provider LastName | MACHADO | |
| NPPES Provider FirstName | ROBERTO | |
| NPPES Provider ZIPCode | 606124325 | |
| NPPES Provider State | IL | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 395.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 3.54 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942268172 |
| Last Name Of The Provider | MACHADO |
| First Name Of The Provider | ROBERTO |
| View All |
Similar Doctors
|
|
Dr. Jacklyn M. Hagedorn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sherene S. Fakhran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Israel R. Rubinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Sjoding, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard A. Jaffe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carmen M. Rosario, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil Shea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Stacie R. Ward, MS |
|
|
Dr. Catherine M. Monti, MD
This Doctor is OpenDoctor Recommended.
|